IKAROS Associated Immunodeficiency and Thrombotic Thrombocytopenic Purpura
ABSTRACT Pathogenic variants in IKZF1 (IKAROS) are linked to immunodeficiency, malignancy, and immune dysregulation. We describe a family with a rare IKZF1 variant presenting with humoral immunodeficiency and thrombotic thrombocytopenic purpura (TTP). A non‐consanguineous family was clinically monitored; clinical, immunological, and genetic data (exome
Ilia Spivak +7 more
wiley +1 more source
PP27. Tumour necrosis factor-α levels are elevated in adolescent patients with juvenile idiopathic arthritis on etanercept therapy [PDF]
Anna Radziszewska +5 more
openalex +1 more source
Extensive triple vessel coronary artery disease in a young male with juvenile idiopathic arthritis [PDF]
Nqoba Tsabedze +3 more
openalex +1 more source
Low ICU Admission and Excellent Outcomes in MIS‐C: A Swedish Study From an Open Society
ABSTRACT Aim During the COVID‐19 pandemic, Sweden chose a more open public health approach. A general concern was that this approach would affect the population negatively. We describe the Swedish national MIS‐C cohort and risk factors for severe disease defined as admission to the intensive care unit and cardiogenic shock.
Petra Król +13 more
wiley +1 more source
Background Low-dose weekly methotrexate (MTX) is the mainstay of treatment in juvenile idiopathic arthritis. Unfortunately, a substantial part of patients has insufficient efficacy of MTX.
Julia E. Möhlmann +7 more
doaj +1 more source
THU0637 ACADEMIC ACHIEVEMENT, EMPLOYMENT STATUS, WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN ADULTS WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA): DETERMINANTS AND CONSEQUENCES [PDF]
Chengappa Kavadichanda +2 more
openalex +1 more source
Development of Inflammatory Bowel Disease in Patients with Juvenile Idiopathic Arthritis Treated with Etanercept [PDF]
TRUDY D. van DIJKEN +12 more
openalex +1 more source
Tumour necrosis factor receptor II polymorphism and juvenile idiopathic arthritis [PDF]
Eleftheria Zeggini
openalex +1 more source

